SPONSOR
Institut Cancerologie de l'Ouest
Total Trials
3
Recruiting
3
Phases
Phase 3
Institut Cancerologie de l'Ouest is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Radionecrosis of Brain, Brain Metastases, Solid Carcinoma, Breast Cancer.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Institut Cancerologie de l'Ouest
How many clinical trials has Institut Cancerologie de l'Ouest sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Institut Cancerologie de l'Ouest, of which 3 are actively recruiting participants. These trials cover conditions including Radionecrosis of Brain, Brain Metastases, Solid Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Institut Cancerologie de l'Ouest research focus on?
Institut Cancerologie de l'Ouest clinical trials span Radionecrosis of Brain, Brain Metastases, Solid Carcinoma, Breast Cancer. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Institut Cancerologie de l'Ouest clinical trial?
To participate in a Institut Cancerologie de l'Ouest trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Institut Cancerologie de l'Ouest trials with current recruitment status updated daily.
Clinical Trials by Institut Cancerologie de l'Ouest
NCT06471465 Phase 3
Recruiting
Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases
Radionecrosis of Brain
NCT06051214
Recruiting
Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk
Solid Carcinoma
NCT05981326
Recruiting
Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology